ArticleFrontiers in pharmacology2025

TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response.

Juntao Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.